Using egg yolk powder to treat severe traumatic brain injury
Official title: Evaluation of Antisecretory Factor in Treatment of Severe Traumatic Brain Injury With Multimodal Monitoring
Run by Skane University Hospital · NCT04117672 · Data updated 2026-11-12
This study is testing if an egg yolk powder can help improve recovery for people with severe traumatic brain injuries when added to their regular treatment.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 10 Years to 70 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Skane University Hospital Academic / other |
| Locations | 1 site (Lund) |
| Status | Recruiting |
| Started | March 10, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | January 21, 2026 |
| Trial ID | NCT04117672 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with severe traumatic brain injury and a Glasgow Outcome Scale score of less than 9 upon admission.
✕Probably not a fit
Patients with known egg yolk allergies or those with fixed and dilated pupils after initial surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of Salovum, an egg yolk powder enriched with antisecretory factor, in addition to standard care for patients with severe traumatic brain injury. Participants will be randomly assigned to receive either Salovum or a placebo egg yolk powder, and various parameters such as intracranial pressure, brain oxygen levels, and inflammatory markers will be monitored. The goal is to assess whether Salovum can reduce cerebral edema and improve patient outcomes compared to standard treatment alone.
Why it matters
Potential benefit: If successful, this treatment could significantly improve recovery outcomes for patients with severe traumatic brain injury.
How similar studies have gone: Preliminary results from similar studies have shown promise in reducing intracranial pressure and improving outcomes in traumatic brain injury.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Severe traumatic brain injury, Glasgow Outcome Scale (GCS) \<9 at admission to NICU. Clinical indication for insertion of intracranial pressure monitor, intracerebral oxygen pressure monitor and microdialysis catheter. Consultation with relatives or consent from guardians. Exclusion Criteria: Known egg yolk allergy. Unilateral or bilateral fixed and dilated pupil after initial operative intervention.
Where it's running
-
Skane University Hopsital
Lund, Sweden Recruiting
Study contacts
- Principal investigator: Peter Siesjö, MD, PhD — Skane University Hospital
- Study coordinator: Peter Siesjö, MD, PhD
- Email: peter.siesjo@med.lu.se
- Phone: +4646171274
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Depth Electrode Monitoring after Traumatic Brain Injury
This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.
-
Understanding growth hormone deficiency after a brain injury in adults
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
-
ZEPU-2000 robotic rehab for arm and leg weakness
This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.